Blueshift Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Blueshift Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$111K	Buy	+11,654	New	+$90.5K	0.03%	473
2022 Q1	–	Sell	-31,910	Closed	-$442K	–	833
2021 Q4	$442K	Buy	31,910 +11,348	+55%	+$150K	0.04%	517
2021 Q3	$295K	Buy	+20,562	New	+$324K	0.02%	822
2021 Q2	–	Sell	-57,655	Closed	-$586K	–	918
2021 Q1	$586K	Buy	+57,655	New	+$594K	0.06%	427

Other funds holding BCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return